Clinical Trials Browser

Phase 3 × Sorafenib × 30 days × Clear all

NCT04039607 2026-04-06

CheckMate 9DW

Phase 3 Active not recruiting

732 enrolled 3 FDA

Gastrointestinal

Carcinoma, Hepatocellular

NCT03298451 2026-03-20

HIMALAYA

Phase 3 Active not recruiting

1,324 enrolled 31 charts 2 FDA

Gastrointestinal

Carcinoma, Hepatocellular

NCT07463651 2026-03-20

TROPHY-15

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute